Blood Preparation Market Size To Reach USD 63.57 Billion By 2028 | Top Key Players Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc

August 20 23:38 2021
Blood Preparation Market Size To Reach USD 63.57 Billion By 2028 | Top Key Players Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc
Increasing blood transfusion procedures and growing use of blood components and derivatives in surgical procedures to bolster market growth

The global blood preparation market size is expected to reach USD 63.57 billion by 2028 at a CAGR of 5.8%, according to the latest report by Reports and Data. Revenue growth of this market is mainly attributed to rising prevalence of blood-related disorders, increasing blood transfusion procedures, growing applications of blood components and derivatives in various surgical procedures, and increasing awareness about blood donation. Market growth is further accelerated by rising road accidents, increasing efforts to prevent thrombosis-associated complications, and development of anti-thrombotic and anti-coagulant drugs. Technological advancements in blood preparation methods and growing usage of blood derivatives such as platelet-rich plasma in procedures such as blood transfusion further bolster the global blood preparation market growth.

Blood preparation is the preparation of vital blood components including platelets, plasma, Red Blood Cells (RBCs), and White Blood Cells (WBCs). The method was first developed in 1960 to separate blood components from whole blood using a refrigerated centrifuge. Whole blood comprises crystalloids, colloids, and cells, and these are separated into different blood components such as platelet concentrates, Packed Red Blood Cell (PRBC) concentrate, frozen plasma, and cryoprecipitate. Blood components are prepared by the centrifugation of a single unit of whole blood. Blood preparation is carried out in clinical laboratories and blood centers.  The method is extensively used in procedures such as blood transfusions.

Get a sample of the report @

Key Highlights of the Report:

  • Based on product type, whole blood segment is expected to account for highest revenue share in the global blood preparation market over the forecast years. Advantages associated with whole blood, such as low costs and easy availability, rising applications in blood transfusions, rising prevalence of life-threatening infectious diseases, and increasing R&D activities to develop blood products, are expected to drive the growth of this segment.
  • Based on application, angina blood vessel complications segment leads the global market in terms of revenue. This segment’s growth is primarily supported by rising prevalence of Cardiovascular Disorders (CVDs), increasing surgical procedures globally, rise in development of advanced anticoagulants, and growing awareness about cardiovascular health.
  • Among the key regional markets, the North America blood preparation market expected to exhibit the highest revenue growth rate during the forecast period. Rising prevalence of blood cancer, expanding blood donation initiatives, and increasing research & development activities for blood components and derivatives are the pivotal factors accountable for the North America market growth.
  • Johnson & Johnson, GlaxoSmithKline PLC, Pfizer Inc., Celgene Corp, Baxter Healthcare Corp., AstraZeneca Co., Boehringer Ingelheim, Sanofi Aventis, Aralez Pharmaceuticals, Bristol-Myers Squibb Co., Leo Pharma Inc., Daiichi Sankyo, Shandong East Chemical Industry Co., Ionis Pharmaceuticals, and Bayer AG are among the top companies involved in the global blood preparation

Request a discount on the report @

For the purpose of this report, the global blood preparation market has been segmented based on the product type, antithrombotic and anticoagulant type, application, and region:

By Product Type (Revenue, USD Billion; 2018-2028)

  • Whole Blood
    • Red Cells
    • Platelets
    • Granulocytes
    • Plasma
  • Blood Components
    • Whole Blood Components
    • Leukocyte Reduced Red Blood Cells
    • Platelet Concentrates
    • Cryoprecipitate
    • Packed Red Cells
    • Frozen Plasma
  • Blood Derivatives

By Antithrombotic and Anticoagulant Type (Revenue, USD Billion; 2018-2028)

  • Platelet Aggregation Inhibitors
    • Glycoprotein Inhibitors
    • ADP Antagonists
    • COX Inhibitors
    • Others
  • Fibrinolytics
    • Tissue Plasminogen Activator (tPA)
    • Urokinase
    • Streptokinase
  • Anticoagulants
    • Heparins
      • Ultra-low Molecular Weight Heparin
      • Low Molecular Weight Heparin (LMWH)
      • Unfractionated Heparin
    • Vitamin K Antagonists
    • Direct Factor Xa Inhibitors
    • Direct Thrombin Inhibitors

By Application (Revenue, USD Billion; 2018-2028)

  • Angina Blood Vessel Complications
  • Pulmonary Embolism
  • Thrombocytosis
  • Renal Impairment
  • Others

By Region (Revenue, USD Billion; 2018-2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request a customization of the report @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States